Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria (English)
- New search for: Sho, Takuya
- New search for: Suda, Goki
- New search for: Ogawa, Koji
- New search for: Kimura, Megumi
- New search for: Kubo, Akinori
- New search for: Tokuchi, Yoshimasa
- New search for: Kitagataya, Takashi
- New search for: Maehara, Osamu
- New search for: Ohnishi, Shunsuke
- New search for: Shigesawa, Taku
- New search for: Nakamura, Akihisa
- New search for: Yamada, Ren
- New search for: Ohara, Masatsugu
- New search for: Kawagishi, Naoki
- New search for: Natsuizaka, Mitsuteru
- New search for: Nakai, Masato
- New search for: Morikawa, Kenichi
- New search for: Furuya, Ken
- New search for: Baba, Masaru
- New search for: Yamamoto, Yoshiya
- New search for: Suzuki, Kazuharu
- New search for: Izumi, Takaaki
- New search for: Meguro, Takashi
- New search for: Terashita, Katsumi
- New search for: Ito, Jun
- New search for: Miyagishima, Takuto
- New search for: Sakamoto, Naoya
- New search for: Sho, Takuya
- New search for: Suda, Goki
- New search for: Ogawa, Koji
- New search for: Kimura, Megumi
- New search for: Kubo, Akinori
- New search for: Tokuchi, Yoshimasa
- New search for: Kitagataya, Takashi
- New search for: Maehara, Osamu
- New search for: Ohnishi, Shunsuke
- New search for: Shigesawa, Taku
- New search for: Nakamura, Akihisa
- New search for: Yamada, Ren
- New search for: Ohara, Masatsugu
- New search for: Kawagishi, Naoki
- New search for: Natsuizaka, Mitsuteru
- New search for: Nakai, Masato
- New search for: Morikawa, Kenichi
- New search for: Furuya, Ken
- New search for: Baba, Masaru
- New search for: Yamamoto, Yoshiya
- New search for: Suzuki, Kazuharu
- New search for: Izumi, Takaaki
- New search for: Meguro, Takashi
- New search for: Terashita, Katsumi
- New search for: Ito, Jun
- New search for: Miyagishima, Takuto
- New search for: Sakamoto, Naoya
In:
Hepatology Research
;
51
, 9
;
979-989
;
2021
- Article (Journal) / Electronic Resource
-
Title:Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria
-
Contributors:Sho, Takuya ( author ) / Suda, Goki ( author ) / Ogawa, Koji ( author ) / Kimura, Megumi ( author ) / Kubo, Akinori ( author ) / Tokuchi, Yoshimasa ( author ) / Kitagataya, Takashi ( author ) / Maehara, Osamu ( author ) / Ohnishi, Shunsuke ( author ) / Shigesawa, Taku ( author )
-
Published in:Hepatology Research ; 51, 9 ; 979-989
-
Publisher:
-
Publication date:2021-09-01
-
Size:11 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 51, Issue 9
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 919
-
Issue Information| 2021
- 921
-
Available weapons in our arsenal for de novo antibody‐mediated rejection following liver transplantation—Fighting an invisible foeEguchi, Susumu et al. | 2021
- 923
-
Clinical usefulness of noninvasive fibrosis indices for predicting hepatocellular carcinoma in treatment‐naïve patients with chronic hepatitis B following entecavir therapyJeong, Joonho / Shin, Jung Woo / Jung, Seok Won / Lee, Seung Bum / Park, Eun Ji / Park, Neung Hwa et al. | 2021
- 933
-
aMAP score prediction of hepatocellular carcinoma occurrence and incidence‐free rate after a sustained virologic response in chronic hepatitis CYamashita, Yuki / Joshita, Satoru / Sugiura, Ayumi / Yamazaki, Tomoo / Kobayashi, Hiroyuki / Wakabayashi, Shun‐ichi / Yamada, Yosuke / Shibata, Soichiro / Kunimoto, Hideo / Iwadare, Takanobu et al. | 2021
- 943
-
Efficacy and safety of apararenone (MT‐3995) in patients with nonalcoholic steatohepatitis: A randomized controlled studyOkanoue, Takeshi / Sakamoto, Michiie / Harada, Kenichi / Inagaki, Masaya / Totsuka, Naoko / Hashimoto, Gaia / Kumada, Hiromitsu et al. | 2021
- 957
-
Reduced handgrip strength predicts poorer survival in chronic liver diseases: A large multicenter study in JapanNishikawa, Hiroki / Shiraki, Makoto / Hiramatsu, Akira / Hara, Nagisa / Moriya, Kyoji / Hino, Keisuke / Koike, Kazuhiko et al. | 2021
- 968
-
Prospective study for an independent predictor of prognosis in liver cirrhosis based on the new sarcopenia criteria produced by the Japan Society of HepatologyKikuchi, Nahoko / Uojima, Haruki / Hidaka, Hisashi / Iwasaki, Shuichiro / Wada, Naohisa / Kubota, Kousuke / Nakazawa, Takahide / Shibuya, Akitaka / Fujikawa, Tomoaki / Kako, Makoto et al. | 2021
- 979
-
Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteriaSho, Takuya / Suda, Goki / Ogawa, Koji / Kimura, Megumi / Kubo, Akinori / Tokuchi, Yoshimasa / Kitagataya, Takashi / Maehara, Osamu / Ohnishi, Shunsuke / Shigesawa, Taku et al. | 2021
- 990
-
The efficacy of rituximab treatment for antibody‐mediated rejection in liver transplantation: A retrospective Japanese nationwide studySakamoto, Seisuke / Akamatsu, Nobuhisa / Hasegawa, Kiyoshi / Ohdan, Hideki / Nakagawa, Ken / Egawa, Hiroto et al. | 2021
- 1000
-
Pathological characteristics of liver sinusoidal thrombosis in COVID‐19 patients: A series of 43 casesKondo, Reiichiro / Kawaguchi, Nao / McConnell, Matthew J. / Sonzogni, Aurelio / Licini, Lisa / Valle, Clarissa / Bonaffini, Pietro A. / Sironi, Sandro / Alessio, Maria Grazia / Previtali, Giulia et al. | 2021